Clinical Trial Update: Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine. [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the long-term safety, tolerability, and efficacy of dalfampridine for post-ischemic stroke was terminated, with results posted in Aug…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Dalfampridine (dalfampridine)

Snippet

Sponsor: Acorda Therapeutics | Conditions: Post-ischemic Stroke | Phase 3 | Status: TERMINATED | Results posted: 2018-08-08